Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Huard

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Journal of Leukocyte Biology|February 22, 2023
Spatial heterogeneity for APRIL production by eosinophils in the small intestineNathalie Sturm, Morgane Roger-Margueritat, Fabien Pierrel, et al.
Arthritis Research & Therapy|October 1, 2009
Synovial tissues concentrate secreted APRILCem Gabay, Veit Krenn, Carine Bosshard, et al.
Cancer Research|May 19, 2007
Extralymphatic tumors prepare draining lymph nodes to invasion via a T-cell cross-tolerance processOlivier Preynat-Seauve, Emmanuel Contassot, Prisca Schuler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejectionOlivier Preynat-Seauve, Prisca Schuler, Emmanuel Contassot, et al.
Plos One|February 23, 2012
Selective APRIL blockade delays systemic lupus erythematosus in mouseBertrand Huard, Ngoc Lan Tran, Mahdia Benkhoucha, et al.
European Journal of Immunology|November 2, 2004
Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytesLionel Arlettaz, Jean Villard, Casimir de Rham, et al.
Seminars in Immunopathology|October 25, 2008
Reconstitution of the immune system after hematopoietic stem cell transplantation in humansJan Storek, Michelle Geddes, Faisal Khan, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 23, 2006
A CD40-CD95L fusion protein interferes with CD40L-induced prosurvival signaling and allows membrane CD40L-restricted activation of CD95Constance Assohou-Luty, Jeanette Gerspach, Daniela Siegmund, et al.
Plos One|September 9, 2015
Pathogenic Role of a Proliferation-Inducing Ligand (APRIL) in Murine IgA NephropathyYang Gyun Kim, Montserrat Alvarez, Hitoshi Suzuki, et al.
Frontiers in Immunology|September 6, 2021
Polarized Secretion of APRIL by the Tonsil Epithelium Upon Toll-Like Receptor StimulationNathalie Sturm, Melanie Quinterot, Jean-Philippe Guyot, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Journal of Leukocyte Biology|February 22, 2023
Spatial heterogeneity for APRIL production by eosinophils in the small intestineNathalie Sturm, Morgane Roger-Margueritat, Fabien Pierrel, et al.
Arthritis Research & Therapy|October 1, 2009
Synovial tissues concentrate secreted APRILCem Gabay, Veit Krenn, Carine Bosshard, et al.
Cancer Research|May 19, 2007
Extralymphatic tumors prepare draining lymph nodes to invasion via a T-cell cross-tolerance processOlivier Preynat-Seauve, Emmanuel Contassot, Prisca Schuler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejectionOlivier Preynat-Seauve, Prisca Schuler, Emmanuel Contassot, et al.
Plos One|February 23, 2012
Selective APRIL blockade delays systemic lupus erythematosus in mouseBertrand Huard, Ngoc Lan Tran, Mahdia Benkhoucha, et al.
European Journal of Immunology|November 2, 2004
Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytesLionel Arlettaz, Jean Villard, Casimir de Rham, et al.
Seminars in Immunopathology|October 25, 2008
Reconstitution of the immune system after hematopoietic stem cell transplantation in humansJan Storek, Michelle Geddes, Faisal Khan, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 23, 2006
A CD40-CD95L fusion protein interferes with CD40L-induced prosurvival signaling and allows membrane CD40L-restricted activation of CD95Constance Assohou-Luty, Jeanette Gerspach, Daniela Siegmund, et al.
Plos One|September 9, 2015
Pathogenic Role of a Proliferation-Inducing Ligand (APRIL) in Murine IgA NephropathyYang Gyun Kim, Montserrat Alvarez, Hitoshi Suzuki, et al.
Frontiers in Immunology|September 6, 2021
Polarized Secretion of APRIL by the Tonsil Epithelium Upon Toll-Like Receptor StimulationNathalie Sturm, Melanie Quinterot, Jean-Philippe Guyot, et al.
Pageof 6